Krystal, John H.

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 3,856

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 3,330

How mental health care should change as a consequence of the COVID-19 pandemic

Moreno, C., Wykes, T., Galderisi, S., Nordentoft, M., Crossley, N., Jones, N., Cannon, M., Correll, C. U., Byrne, L., Carr, S., et al. (2020) · The Lancet Psychiatry

COVID-19 and Mental HealthPsychiatric care and mental health services

Cited by 1,840

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 1,750

Move Over ANOVA: Progress in Analyzing Repeated-Measures Data andIts Reflection in Papers Published in the Archives of General Psychiatry

Gueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry

Statistical Methods and Bayesian InferenceStatistical Methods in Clinical Trials

Cited by 1,529

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 1,291

Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study

Chekroud, S. R., Gueorguieva, R., Zheutlin, A. B., Paulus, M., Krumholz, H. M., Krystal, J. H., & Chekroud, A. M. (2018) · The Lancet Psychiatry

Physical Activity and HealthMental Health Treatment and Access

Cited by 1,172

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 1,026

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis

D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 1,024

The role of default network deactivation in cognition and disease

Anticevic, A., Cole, M. W., Murray, J. D., Corlett, P. R., Wang, X.-J., & Krystal, J. H. (2012) · Trends in Cognitive Sciences

Functional Brain Connectivity StudiesMind wandering and attention

Cited by 978

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 894

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS).

Bremner, J. D., Krystal, J. H., Putnam, F. W., Southwick, S. M., Marmar, C., Charney, D. S., & Mazure, C. M. (1998) · Journal of Traumatic Stress

Psychosomatic Disorders and Their TreatmentsPsychoanalysis and Psychopathology Research

Cited by 817

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

Bremner, J. D., Licinio, J., Darnell, A., Krystal, J. H., Owens, M. J., Southwick, S. M., Nemeroff, C. B., & Charney, D. S. (1997) · American Journal of Psychiatry

Posttraumatic Stress Disorder ResearchStress Responses and Cortisol

Cited by 721

Brain-Derived Neurotrophic Factor–5-HTTLPR Gene Interactions and Environmental Modifiers of Depression in Children

Kaufman, J., Yang, B.-Z., Douglas-Palumberi, H., Grasso, D., Lipschitz, D., Houshyar, S., Krystal, J. H., & Gelernter, J. (2006) · Biological Psychiatry

Neurotransmitter Receptor Influence on BehaviorChild Abuse and Trauma

Cited by 692

Cross-trial prediction of treatment outcome in depression: a machine learning approach

Chekroud, A. M., Zotti, R. J., Shehzad, Z., Gueorguieva, R., Johnson, M. K., Trivedi, M. H., Cannon, T. D., Krystal, J. H., & Corlett, P. R. (2016) · The Lancet Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 676

Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

Sanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry

Treatment of Major DepressionAdvanced MRI Techniques and Applications

Cited by 627

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 617

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 612

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 553

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Krystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 530

Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder

Yehuda, R., Southwick, S. M., Krystal, J. H., Bremner, J. D., Charney, D. S., & Mason, J. W. (1993) · American Journal of Psychiatry

Stress Responses and CortisolPosttraumatic Stress Disorder Research

Cited by 517

A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.

Scott, J. C., Matt, G. E., Wrocklage, K. M., Crnich, C., Jordan, J., Southwick, S. M., Krystal, J. H., & Schweinsburg, B. C. (2015) · Psychological Bulletin

Posttraumatic Stress Disorder ResearchTraumatic Brain Injury Research

Cited by 513

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy

Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry

Memory and Neural MechanismsPosttraumatic Stress Disorder Research

Cited by 510

Smaller hippocampal volume in posttraumatic stress disorder: a multisite ENIGMA-PGC study: subcortical volumetry results from posttraumatic stress disorder consortia

Logue, M. W., van Rooij, S. J. H., Dennis, E. L., Davis, S. L., Hayes, J. P., Stevens, J. S., Densmore, M., Haswell, C. C., Ipser, J., Koch, S. B. J., et al. (2018) · Biological Psychiatry

Posttraumatic Stress Disorder ResearchTraumatic Brain Injury Research

Cited by 487